SB 1366: Compounding drugs; exceptions for distribution within hospital or health system. - Virginia

Enrolled → Chaptered · 2 edits

MINOR

The bill was formally enacted into law as Chapter 71 of the 2025 Virginia Acts of Assembly, effective March 18, 2025. This finalizes the legislative process for a law amending the Code of Virginia regarding compounding drugs and hospital distribution exceptions.

Scope change

The bill's scope remains focused on amending § 54.1-3410.2 of the Code of Virginia; no substantive policy scope changes were identified in the text provided.

TECHNICAL

Added the official chapter number (Chapter 71) and the specific approval date (March 18, 2025) to the enrolled text.

Removed the placeholder text indicating the session year and the generic 'Approved' status.

Education and Health Substitute → Enrolled · 3 edits · Mar 18, 2025

MINOR

The bill has transitioned from a draft substitute version to its final enrolled status, making it an official law. The substantive text of the act regarding compounding drug exceptions remains unchanged, indicating the legislative process is complete for this specific version.

Scope change

The bill's scope and applicability are unchanged; only the document's legal status has been updated to reflect final approval.

TECHNICAL

Removed draft headers and committee attribution (e.g., 'OFFERED FOR CONSIDERATION', 'Proposed by the Senate Committee') as the bill is no longer in committee.

Added final legal headers including '2025 SESSION', 'ENROLLED', and 'Approved' to signify the bill has passed all legislative stages.

Replaced the committee-substitute title with the standard enrolled act title format while retaining the same subject matter regarding compounding drugs.

Introduced → Education and Health Substitute · 3 edits

MINOR

The bill was amended to clarify and expand the exceptions for pharmacists distributing compounded drugs within health systems. The changes allow distribution to other entities under common ownership within a health system, provided the drugs are only administered to patients within that same system, while maintaining restrictions on sales to commercial entities.

Scope change

The scope of permitted distribution was expanded to include entities under common ownership within a health system, whereas the original text was ambiguous regarding whether such internal distribution was allowed.

ELIGIBILITY

Clarified that pharmacists may distribute compounded drugs to other pharmacies or entities under common ownership within a health system, as long as the drugs are administered only to patients within that specific hospital or health system.

REQUIREMENT

Removed ambiguous language that previously suggested a hard prohibition on distribution to entities under common ownership, replacing it with a specific exception for internal health system administration.

TIMELINE

Updated the bill status from 'Introduced' on January 13, 2025, to 'Offered for Consideration' on January 30, 2025, reflecting its progression through the legislative process.

Compounding drugs; exceptions for distribution within hospital or health system.

What changed between versions

How they voted

Actions timeline

Sponsors